Vaccination alters the balance between protective immunity, exhaustion, escape, and death in chronic infections

Journal of Virology

Volumn 85, Issue 11, 2011, Pages 5565-5570

  Johnson, Philip L F ^a   Kochin, Beth F ^a   McAfee, Megan S ^b   Stromnes, Ingunn M ^b   Regoes, Roland R ^c   Ahmed, Rafi ^a   Blattman, Joseph N ^b   Antia, Rustom ^a  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE BASED VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONICITY; IMMUNIZATION; IMMUNOPATHOLOGY; LYMPHOCYTIC CHORIOMENINGITIS; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROTECTION; VIRAL CLEARANCE; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS MUTANT;

CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; MODELS, THEORETICAL; VACCINATION; VACCINES; VIRUS DISEASES;

EID: 79956111917     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00166-11     Document Type: Article

References (28)

1. Ando, K., et al. 1994. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J. Immunol. 152:3245-3253.
2. Antia, R., B. R. Levin, and R. M. May. 1994. Within-host population-dynamics and the evolution and maintenance of microparasite virulence. Am. Nat. 144:457-472.
3. Araki, K., et al. 2010. Pathogenic virus-specific T cells cause disease during treatment with the calcineurin inhibitor FK506: implications for transplantation. J. Exp. Med. 207:2355-2367.
4. Badovinac, V. P., S. E. Hamilton, and J. T. Harty. 2003. Viral infection results in massive CD8+ T cell expansion and mortality in vaccinated perforin-deficient mice. Immunity 18:463-474.
5. Blattman, J. N., et al. 2002. Estimating the precursor frequency of naive antigen-specific CD8 T cells. J. Exp. Med. 195:657-664.
6. Blattman, J. N., et al. 2009. Impact of epitope escape on PD-1 expression and CD8 T-cell exhaustion during chronic infection. J. Virol. 83:4386-4394.
7. Bocharov, G. A. 1998. Modelling the dynamics of LCMV infection in mice: conventional and exhaustive CTL responses. J. Theor. Biol. 192:283-308.
8. Chisari, F. V., and C. Ferrari. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:29-60.
9. Ehl, S., P. Klenerman, R. M. Zinkernagel, and G. Bocharov. 1998. The impact of variation in the number of CD8(+) T-cell precursors on the outcome of virus infection. Cell. Immunol. 189:67-73.
10. Fulginiti, V. A., et al. 1969. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am. J. Epidemiol. 89:435-448.
11. Halstead, S. B., and E. J. O'Rourke. 1977. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265:739-741.
12. Hilborn, R., and M. Mangel. 1997. The ecological detective: confronting models with data. Monographs in population biology 28. Princeton University Press, Princeton, NJ.
13. Kapikian, A. Z., R. H. Mitchell, R. M. Chanock, R. A. Shvedoff, and C. E. Stewart. 1969. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89:405-421.
14. Kim, H. W. et al. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:422-434.
15. Krakauer, D. C., and M. Nowak. 1999. T-cell induced pathogenesis in HIV: bystander effects and latent infection. Proc. Biol. Sci. 266:1069-1075.
16. Liu, F., R. Feuer, D. E. Hassett, and J. L. Whitton. 2006. Peptide vaccination of mice immune to LCMV or vaccinia virus causes serious CD8 T cellmediated, TNF-dependent immunopathology. J. Clin. Invest. 116:465-475.
17. May, R. M. 2004. Uses and abuses of mathematics in biology. Science 303:790-793.
18. McElrath, M. J., et al. 2008. HIV-1 vaccine-induced immunity in the testof-concept step study: a case-cohort analysis. Lancet 372:1894-1905.
19. Morens, D. M. 1994. Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clin. Infect. Dis. 19:500-512.
20. Moskophidis, D., E. Laine, and R. M. Zinkernagel. 1993. Peripheral clonal deletion of antiviral memory CD8+ T cells. Eur. J. Immunol. 23:3306-3311.
21. Moskophidis, D., F. Lechner, H. Pircher, and R. M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362:758-761.
22. Oehen, S., H. Hengartner, and R. M. Zinkernagel. 1991. Vaccination for disease. Science 251:195-198.
23. Perelson, A. S. 2002. Modelling viral and immune system dynamics. Nat. Rev. Immunol. 2:28-36.
24. Reiley, W. W., et al. 2010. Distinct functions of antigen-specific CD4 T cells during murine Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. U. S. A. 107:19408-19413.
25. Rouzine, I. M., K. Murali-Krishna, and R. Ahmed. 2005. Generals die in friendly fire, or modeling immune response to HIV. J. Comput. Appl. Math. 184:258-274.
26. Wherry, E. J., and R. Ahmed. 2004. Memory CD8 T-cell differentiation during viral infection. J. Virol. 78:5535-5545.
27. Young, D., J. Stark, and D. Kirschner. 2008. Systems biology of persistent infection: tuberculosis as a case study. Nat. Rev. Microbiol. 6:520-528.
28. Zajac, A. J., et al. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:2205-2213.